Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Theramex Says Currently Considering CMA's Decision, In Particular Whether And How Best To Address Competition Concerns Regarding Deal With Viatris; " Co Remains Committed To Offering Women Choice To Make Empowered Decisions About HRT At Competitive Prices For NHS"; Phase 1 Of CMA's Decision To Have No Impact On Co's Ability To Supply Existing HRT Products In UK

Author: Benzinga Newsdesk | April 05, 2024 12:53pm

- Reuters

Posted In: VTRS